Stigma is amorphous: it is structural, embedded in the social fabric; it is expressed as discrimination; and it is internalized in the form of self-blame, deterring some in distress from seeking help. Here in this library find resources for the latest in diagnosis and treatment.
Recognizing the Inner Voice: Breaking the LGBTQIA+ Conversation Barrier
May Mental Health Awareness Month: An Interview With Tara McKinley, PharmDInterviewMay 23, 2022May has been recognized and celebrated as Mental Health Awareness month within the United States since 1949. During the month…
Call To Action: The Need For Stigma Awareness In Healthcare Professional EducationOn-Demand WebinarMarch 9, 2022Recognizing the need for awareness of mental health stigma in healthcare professional education programs can be challenging. In this webinar,…
The Role Of The Pharmacist In Managing Patients With Opioid Use Disorders (OUD): Focus On StigmaInterviewDecember 10, 2021In this interview, Bethany DiPaula, PharmD, BCPP, FASHP addresses the issue of stigmatization of patients with OUD, steps pharmacists can…
In 2022, 20.8% Of U.S. Adults Were Experiencing A Mental Illness
People Diagnosed With A Mental Disorder On Average Work 10.5 Years Less Compared With The General PopulationArticleDecember 26, 2022
Dimensions Of Health & Wellness: De-stressing During Stressful TimesInterviewNovember 21, 2022
United Health Foundation Launches $3 Million Partnership With Active Minds To Help Address The Youth Mental Health CrisisArticleNovember 7, 2022
Ask A Question About Stigma
Enter your question in the box below and click “Ask My Question” to submit your inquiry.
You must be logged in to ask a question in this section.
Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.
REQUEST A PRESENTATION
Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.
Top Requested Presentations
The Neuropsychiatric Inventory: Development & Applications
Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR
Distinguishing Sedation From Efficacy In Antipsychotic Treatment